(Q34626882)

English

The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Philip G Conaghan

6

object named as

Philip G Conaghan

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Désirée van der Heijde

3

object named as

Désirée van der Heijde

0 references

11

object named as

Mahboob U Rahman

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Roy Fleischmann

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Edward C Keystone

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mark C Genovese

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Elizabeth C Hsia

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Weichun Xu

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Anna Baratelle

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Anna Beutler

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1200-1210

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Predictors of radiographic joint damage in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.30263

21 January 2018

Identifiers

10.1002/ART.30263

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34626882&oldid=1959659506"